An improved bidentate phosphine-modified Ru catalytic system was developed for the selective reduction of levulinic acid to γ-valerolactone.
No takes yet. Share an insight, caveat, or question.
Tukacs et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Catalysis Science & Technology